Login

Cidara Therapeutics, Inc. SEC Filings

Filed On Filing
17 Feb 2026 SCHEDULE 13G/A
17 Feb 2026 SCHEDULE 13G/A
13 Feb 2026 SCHEDULE 13G/A
30 Jan 2026 SCHEDULE 13G
20 Jan 2026 15-12G
09 Jan 2026 EFFECT
09 Jan 2026 EFFECT
09 Jan 2026 EFFECT
09 Jan 2026 EFFECT
09 Jan 2026 EFFECT
09 Jan 2026 EFFECT
09 Jan 2026 SCHEDULE 13D/A
09 Jan 2026 Form 4: Ra Capital MANAGEMENT, L.p., Director and 3 others

Received 1,286,786 shares by exercise or conversion ($129) · Returned 4,652,309 shares to the issuer ($1.03B) · Disposed of 27,279 Stock Option (right to buy) (Disposition to Issuer) · 1 more

07 Jan 2026 Form 4: Spencer Ryan, Director

Disposed of 17,475 Stock Option (right to buy) (Disposition to Issuer)

07 Jan 2026 Form 4: Merson James, Director

Disposed of 17,475 Stock Option (right to buy) (Disposition to Issuer)

07 Jan 2026 Form 4: Canale-Theakston Carin, Director

Disposed of 35,375 Stock Option (right to buy) (Disposition to Issuer)

07 Jan 2026 Form 4: Resnick Joshua, Director

Disposed of 27,279 Stock Option (right to buy) (Disposition to Issuer)

07 Jan 2026 Form 4: Bassler Bonnie L, Director

Returned 15 shares to the issuer ($3.32K) · Disposed of 35,375 Stock Option (right to buy) (Disposition to Issuer)

07 Jan 2026 Form 4: Mineo Chrysa, Director

Returned 3,320 shares to the issuer ($735K) · Disposed of 39,600 Stock Option (right to buy) (Disposition to Issuer)

07 Jan 2026 Form 4: Schroeder Theodore R, Director

Disposed of 41,100 Stock Option (right to buy) (Disposition to Issuer)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support